Abstract
Fas (CD95/APO-1) is a protein that is mainly related to apoptosis of lymphoid cells. The increment of Fas expression is associated with long-term survival in various malignancies. However, there are limited studies regarding the effect of Fas expression on the course and prognosis of non-Hodgkin's lymphoma. The aim of this study was to investigate the significance of immunohistochemical Fas expression on the prognosis of nodal diffuse large B-cell lymphoma. A total of 63 patients with primary nodal diffuse large B-cell lymphoma diagnosed in the Erciyes University Department of Hematology between 1990 and 2003 were included in the study. The median age of the patients was 55 years old (range 19-102 years old). The median follow-up period was 19 months (2-132 months). Histopathological sections were stained immunohistochemically and evaluated by light microscopy for Fas, bcl-2, and p53. Clinical and laboratory parameters including Fas, bcl-2, and p53 positivity, age, sex, performance status, clinical stage, presence of B symptoms, bone marrow involvement, extranodal involvement, and lactic dehydrogenase levels were evaluated to compare overall survival. Complete remission was obtained in 28 patients (44.4%) after first-line chemo...Continue Reading
References
Aug 1, 1972·British Journal of Cancer·J F KerrA R Currie
Dec 1, 1995·Cellular Immunology·A H MontelZ Brahmi
Mar 10, 1995·Science·S Nagata, P Golstein
Mar 1, 1995·Leukemia & Lymphoma·M J RobertsonJ Ritz
Jul 1, 1995·Cellular Immunology·M el-KhatibS T Ju
Jun 1, 1995·Pathology International·M AftabuddinT Akagi
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jul 14, 1994·The New England Journal of Medicine·K OffitA Rosenbaum
Feb 1, 1994·British Journal of Cancer·M A PirisF ] Pezella F [corrected to Pezzella
Aug 1, 1993·Histopathology·J U RijlaarsdamR Willemze
Dec 1, 1995·Immunology Today·D H LynchM R Alderson
Jun 14, 1996·Cell·A Fraser, G Evan
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H KramerP M Kluin
Oct 18, 1996·Cell·J C RathmellC C Goodnow
Oct 23, 1997·Journal of Cutaneous Pathology·C W van HaselenR Willemze
Apr 29, 1998·Internal Medicine·S Nagata
Aug 4, 1998·European Journal of Biochemistry·K Schulze-OsthoffM E Peter
Sep 30, 1998·Cell·D R Green
Jan 29, 1999·Human Pathology·C S NgJ K Chan
Apr 6, 1999·The Journal of Experimental Medicine·T MaedaS Kamihira
Jun 17, 1999·International Journal of Cancer. Journal International Du Cancer·R Koomägi, M Volm
Jul 10, 1999·The International Journal of Biochemistry & Cell Biology·A Strasser, K Newton
Jan 12, 2000·The Journal of Pathology·O Zoi-ToliR Willemze
Feb 7, 2001·International Journal of Cancer. Journal International Du Cancer·M MottoleseF M Venanzi
Jul 6, 2000·Science·F K ChanM J Lenardo
Aug 22, 2000·The British Journal of Dermatology·O Zoi-ToliR Willemze
Jul 10, 2001·Head & Neck·M C JäckelL Füzesi
Nov 8, 2001·Leukemia & Lymphoma·T H LandowskiW S Dalton
Jan 5, 2002·Hematological Oncology·J K Chan
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Jun 1, 2002·Science·Harald Wajant
Jul 4, 2002·Oncogene·Tetsuya TakakuwaKatsuyuki Aozasa
Citations
Apr 17, 2010·Molecules and Cells·E ShunmeiJiangying Zou
Oct 28, 2009·Experimental Hematology·Sabine NagelAlexandar Tzankov
Mar 9, 2007·Immunology·Naama Peshes-YalozGideon Berke
Jan 5, 2011·European Journal of Haematology·Olivera MarkovicBiljana Mihaljevic
Feb 7, 2015·Cell Death and Differentiation·M E PeterP Ceppi
May 17, 2017·Cytometry. Part B, Clinical Cytometry·Chandra Chiappin CardosoMaria Claudia Santos-Silva
Oct 5, 2006·American Journal of Hematology·Victor Piana de Andrade, Fernando Augusto Soares